Cargando…
Cancer-associated thrombosis: prevention and treatment
Patients with cancer are at high risk to develop venous thromboembolism, and they are also more likely to develop complications from anticoagulant treatment. Because little research has focused on the oncology population to date, the optimal methods of prophylaxis and treatment remain uncertain in s...
Autores principales: | Brose, K.M.J., Lee, A.Y.Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216419/ https://www.ncbi.nlm.nih.gov/pubmed/18231650 |
Ejemplares similares
-
Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010) -
Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada
por: Attard, C.L., et al.
Publicado: (2010) -
An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor– positive early breast cancer
por: Verma, S., et al.
Publicado: (2009) -
Autoimmune blistering disorders in the setting of human immunodeficiency virus infection()
por: Min, M.S., et al.
Publicado: (2018) -
Cancer treatment–related bone loss: a review and synthesis of the literature
por: Khan, M.N., et al.
Publicado: (2008)